D-1480-2016 Class II Terminated
FDA drug recall D-1480-2016 was initiated by Isomeric Pharmacy Solution, LLC on Jun 29, 2016 and is designated Class II. Reason for recall: Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable… The recall status is terminated (terminated Dec 20, 2016). Affected quantity: 274 multdose vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 14, 2016
- Initiation Date
- Jun 29, 2016
- Termination Date
- Dec 20, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 274 multdose vials
Product description
Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial, sterile. Rx only. Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109,
Reason for recall
Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.
Distribution pattern
Nationwide and Puerto Rico. No Canadian, other foreign, govt/VA/military consignees.
Code information
Lots# 03045 and 03046; Exp. 10/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1480-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026